Fulgent Genetics, Inc. FLGT Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s accrued expenses and other liabilities?
- Fulgent Genetics, Inc. (FLGT) reported accrued expenses and other liabilities of -$2.12M in Q1 2026.
- How has Fulgent Genetics, Inc.'s accrued expenses and other liabilities changed year-over-year?
- Fulgent Genetics, Inc.'s accrued expenses and other liabilities increased by 71.6% year-over-year, from -$7.49M to -$2.12M.